Lisa Lewis has built her career over twenty-five years in biomedical research, from bench to bedside and from academia to the pharmaceutical industry. She is passionate about health equity, inclusive research, and responsible innovation. She has held leadership and consulting roles in clinical development, medical affairs, clinical operations, and other functions at companies including Johnson & Johnson, Novartis Oncology, Celgene, Bristol-Myers Squibb, Flatiron Health, The Medicines Company, AstraZeneca, G1 Therapeutics, Allergan, and Immunocore. 

Lewis began her career as a research technologist in the Hematopoiesis Research Laboratory at the Division of Pediatric Hematology/Oncology at Mount Sinai Hospital/Icahn School of Medicine and Northwell Health. Early in her career, she managed pediatric hematology/oncology cooperative group clinical trials at Mount Sinai Hospital and had the privilege of working directly with cancer patients, clinical trial participants, families, and caregivers as research manager at Queens Medical Associates Center for Cancer and Blood Disorders at Northwell Health in Fresh Meadows, NY. She also served as a research associate at The New York Academy of Medicine for the Center for Adherence Support Evaluation.

Most recently, Lewis served as director of diversity, equity, and inclusion in clinical trials (DEICT)–Oncology at Johnson & Johnson (J&J) Innovative Medicine, where she led the DEICT oncology team and collaborated with senior leaders and global functional teams across clinical development, medical affairs, regulatory affairs, patient advocacy, and patient engagement. At J&J, she co-led the internal Oncology Diversity and Inclusion (D&I) in Clinical Trials internal Steering Committee, and she led a 280+ employee Oncology D&I in Clinical Trials Community of Practice. She was a member of the J&J Bioethics Committee and co-lead of the J&J/Janssen Oncology DEI Council. Lewis played a key role in collaborations to advance equity in oncology care and clinical research, including the Stand Up to Cancer Diversity in Early Development Clinical Trials Program and the Navigating Patients Across the Care and Treatment Continuum program with the American Cancer Society—both of which were featured in the White House Cancer Moonshot Progress Update.

Lewis is also passionate about supporting the next generation of entrepreneurs, students, and leaders in life sciences and STEM. She was selected by the Social Impact team at LinkedIn as a volunteer Career Advisor in a pilot program launched by LinkedIn in partnership with the City University of New York. Lewis was an application reviewer for the Black Ambition Prize, launched by Black Ambition, a nonprofit initiative founded by Pharrell Williams. She also participated in the Dana Farber/Harvard Cancer Center Continuing Umbrella of Research Experiences (DF/HCC CURE) Beyond Academia virtual workshop. where she joined 30+ leaders to share her career journey and career advice with High School and College students. Lisa is an active member of professional organizations, including The Cru - Empowered by Luminary, where she led their Healthcare, Life Sciences, and STEM Cohort. She is also a member of the American Society of Bioethics and Humanities, the American Society of Human Genetics, Women in Bio, and the National Council of Negro Women.

She holds a bachelor of science in biology/pre-medicine from Stony Brook University, master of public health with a concentration in health informatics from New York Medical College. She is currently pursuing a master of science in bioethics at the Harvard Medical School Center for Bioethics. Lewis has completed certificates in leadership development to advance equity in health care at the Harvard T.H. Chan School of Public Health, and Media and Medicine: How to Tell Stories That Make a Difference, under Neal Baer and Suzanne Koven at Harvard Medical School, Blavatnik Institute, Department of Global Health and Social Medicine. She has also completed executive education coursework in data visualization and management at New York University and The Wharton School of the University of Pennsylvania.